CXCL2/10/12/14 are prognostic biomarkers and correlated with immune infiltration in hepatocellular carcinoma.

Tong LinE ZhangPei-Pei MaiYing-Zhao ZhangXiang ChenLi-Sheng Peng

Published in: Bioscience reports (2022)

The present study proposed CXCL2/10/12/14 might predict outcomes of HCC patients and were extensively related with the immune microenvironment in HCC. It would be a prospective therapeutic strategy for HCC to enhance effective immunity surveillance through intervening in these CXCLs.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
stem cells
peritoneal dialysis
prognostic factors
multidrug resistant
type diabetes
metabolic syndrome